Jefferies Financial Group Invests $2.43M in Bio-Techne Corp

The investment firm bought 43,653 shares of the biotechnology company's stock in Q3.

Published on Mar. 11, 2026

Got story updates? Submit your updates here. ›

Jefferies Financial Group Inc. has made a new $2.43 million investment in Bio-Techne Corp (NASDAQ:TECH), purchasing 43,653 shares of the biotechnology company's stock in the third quarter according to a recent SEC filing.

Why it matters

The investment by Jefferies, a major global investment banking and capital markets firm, signals confidence in Bio-Techne's growth potential. Bio-Techne is a leading developer of high-quality reagents, instruments and services for the life sciences research, diagnostic and bioprocessing markets.

The details

Jefferies bought the 43,653 shares of Bio-Techne stock, valued at approximately $2.43 million, in the third quarter. Other major institutional investors in Bio-Techne include Neuberger Berman Group, Champlain Investment Partners, and Mackenzie Financial Corp.

  • Jefferies made the investment in Bio-Techne stock during the third quarter of the year.

The players

Jefferies Financial Group Inc.

A global investment banking and capital markets firm.

Bio-Techne Corp

A leading developer of high-quality reagents, instruments and services for the life sciences research, diagnostic and bioprocessing markets.

Got photos? Submit your photos here. ›

The takeaway

Jefferies' investment in Bio-Techne reflects the firm's confidence in the biotechnology company's growth potential and leadership position in the life sciences industry.